Short Interest to Follow: Is Buying Unilife Corporation (NASDAQ:UNIS), Having Higher Short Interest a Winning Strategy?

November 18, 2016 - By Linda Rogers   ·   0 Comments

Short Interest to Follow: Is Buying Unilife Corporation (NASDAQ:UNIS), Having Higher Short Interest a Winning Strategy?

The stock of Unilife Corporation (NASDAQ:UNIS) registered an increase of 0.4% in short interest. UNIS’s total short interest was 1.15 million shares in November as published by FINRA. Its up 0.4% from 1.15 million shares, reported previously. With 89,400 shares average volume, it will take short sellers 13 days to cover their UNIS’s short positions. The short interest to Unilife Corporation’s float is 7.71%. About 43,241 shares traded hands. Unilife Corp (NASDAQ:UNIS) has declined 51.02% since April 18, 2016 and is downtrending. It has underperformed by 55.45% the S&P500.

Unilife Corporation is engaged in the designing, development and manufacturing of injectable drug delivery systems. The company has a market cap of $46.92 million. The Firm has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. It currently has negative earnings. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients.

Unilife Corp (NASDAQ:UNIS) Ratings Coverage

Out of 3 analysts covering Unilife Corporation (NASDAQ:UNIS), 1 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 33% are positive. Unilife Corporation has been the topic of 7 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The company was maintained on Thursday, September 3 by Griffin Securities. The firm has “Buy” rating given on Monday, January 4 by Griffin Securities. The firm has “Buy” rating by Griffin Securities given on Wednesday, September 16. The firm has “Overweight” rating by Piper Jaffray given on Tuesday, September 15. Jefferies downgraded the shares of UNIS in a report on Thursday, August 6 to “Hold” rating. On Tuesday, March 15 the stock rating was downgraded by Piper Jaffray to “Neutral”. The rating was downgraded by Griffin Securities to “Hold” on Tuesday, October 20.

UNIS Company Profile

Unilife Corporation, incorporated on July 2, 2009, is a medical device maker and component supplier. The Firm is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Firm has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. The Company’s other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care well-known provider or end user without having the device pre-filled by a pharmaceutical company.

More notable recent Unilife Corp (NASDAQ:UNIS) news were published by: Prnewswire.com which released: “Unilife Corporation Provides Business Update” on November 02, 2016, also Reuters.com with their article: “BRIEF-Unilife Corp announces receipt of delinquency letter from Nasdaq” published on September 23, 2016, Prnewswire.com published: “Unilife Corporation Provides Trading Update” on September 29, 2016. More interesting news about Unilife Corp (NASDAQ:UNIS) were released by: Streetinsider.com and their article: “Unilife Corp. (UNIS) Receives Nasdaq Listing Notification” published on September 26, 2016 as well as Streetinsider.com‘s news article titled: “Unilife Corp. (UNIS) Names New CEO; Updates on Cost Reduction Initiatives …” with publication date: July 28, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Linda Rogers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>